Document da8KVrB7N8Gb8zg7RDExdLoE6
NORTHERN KENTUCKY OFFICE SUITE 340
1717 DIXIE HIGHWAY COVINGTON, KENTUCKY 41011-4704
606-331-2838 513-381-2838 FAX: 513-381-6613
DAYTON, OHIO OFFICE SUITE 900
110 NORTH MAIN STREET DAYTON, OHIO 45402-1786
937-228-2838 FAX: 937-228-2816
TAFT, STETTINIUS & HOLLISTER LLP
425 WALNUT STREET, SUITE 1800 CINCINNATI, OHIO 45202-3957
513-381 -2838 FAX: 513-381-0205
www.taftlaw.com
CLEVELAND, OHIO OFFICE 3500 8P TOWER
200 PUBLIC SQUARE CLEVELAND, OHIO 44114-2302
216-241-2638 FAX: 216-241-3707
COLUMBUS, OHIO OFFICE
21 east state street columbus, ohio 43215-1221
614-221-2838 FAX:614-221-2007
R o b er t A. B ilo tt (513) 357-9638
bilott@taftlaw.com
December 5, 2003
TELECOPY AND FEDERAL EXPRESS
Dr. Charles M. Auer Chemical Control Division Office of Prevention, Pesticides
and Toxic Substances United States Environmental Protection
Agency 1201 Constitution Avenue, N.W. Room 3166A Washington, DC 20004
Jennifer Seed United States Environmental Protection
Agency 1201 Constitution Avenue, N.W. Room 6334A Washington, DC 20004
Oscar Hernandez Director, Risk Assessment Division Office of Prevention, Pesticides
and Toxic Substances United States Environmental Protection
Agency 1201 Constitution Avenue, N.W. Room 6220A Washington, DC 20004
John Wheeler, Ph.D. ATSDR 1825 Century Center Blvd. Room 2129 Atlanta, GA 30345
Na
. CC3iU>
rcO~n>
23*
-oir-
Re: Human Health Threat Arising From Releases Of PFOA/APFO/C-8 In West Virginia And Ohio: Supplemental Information_____________
Ladies and Gentlemen:
As a follow up to our letters of February 3, April 4, April 11, May 6, and May 21, 2003 (AR-226-1216,1307, 1308, 1495, and 1493), regarding the health threat to those living near the Washington Works Plant of E.I. duPont de Nemours and Company ("DuPont") located in Wood County, West Virginia, we have enclosed copies of the following documents relating to DuPont's evaluation of the health condition of workers at that DuPont Plant where PFOA has been used in the manufacturing processes since the early 1950s and has been present in the air and plant drinking water:
RECEIVED
W0096349.1
Dr. Charles M. Auer Oscar Hernandez Jennifer Seed John Wheeler, Ph.D. December 5, 2003 Page 2
1. DuPont Internal Memo, "Washington Works Cancer Incidence and Overall Mortality Rates" (12/14/89) (EID521382-92);
2. DuPont Internal Memo, "Washington Works - Surveillance Data: Mortality and Cancer Incidence (8/28/92) (EID521393-401);
3. DuPont Internal Memo, "Washington Works - Surveillance Data: Cancer Incidence" (9/28/92)(EID521402-3);
4. DuPont Internal Memo, "Mortality and Cancer Incidence Surveillance Updates" (9/26/92) (EID521404-5); and
5 Several internal DuPont Washington Works documents regarding claims of infertility among male employees at DuPont's Washington Works Plant (1984) (EED523009-21).-
RAB/mdm Enclosure cc: R. Edison Hill, Esq. (w/o ends.)
Larry A. Winter, Esq. (w/o ends.) Gerald J. Rapien, Esq. (w/o ends.) Mary Dominiak (USEPA, OPPT) (for inclusion in AR-226) (w/ ends.) (Fax & FedEx)
- Several of the pages are marked "Redacted" by DuPont to indicate that employee names or other personal identifying information was redacted from the document prior to production. As a Defendant in a class action lawsuit pending against DuPont in the West Virginia State Court in which we serve as Class counsel, DuPont also has the right to mark documents produced in that case as falling under the terms of a Stipulated Protective Order that allow parties to limit distribution of documents, if they qualify as documents for which "Confidential Business Information" (CBI), protection would be available under, among other provisions, 40 C.F.R. Part 2, Subpart B. None of the enclosed documents have been stamped "confidential" by DuPont under the terms of that Stipulated Protective Order.
W0096349.1
